City Holding CO Gilead Sciences, Inc. Transaction History

City Holding CO

$674 Million
Q4 2024

A detailed history of City Holding CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, City Holding CO holds 300 shares of GILD stock, worth $27,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 300 -0.0%

Holding current value

$27,920

Previous $25,000 8.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$66.59 - $83.99 $30,165 - $38,047	-453 Reduced 60.16%	300 $25,000
Q2 2024 Jul 12, 2024	SELL	$63.15 - $72.88 $41,047 - $47,372	-650 Reduced 46.33%	753 $51,000
Q4 2023 Jan 10, 2024	SELL	$73.27 - $83.09 $11,943 - $13,543	-163 Reduced 10.41%	1,403 $113,000
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $3,844 - $4,194	-52 Reduced 3.21%	1,566 $117,000
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $2,660 - $3,034	-35 Reduced 2.12%	1,618 $124,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $2,181 - $3,131	-35 Reduced 2.07%	1,653 $0
Q3 2022 Oct 12, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 5.59%	1,688 $104,000
Q4 2021 Mar 11, 2022	SELL	$64.88 - $73.64 $35,619 - $40,428	-549 Reduced 23.49%	1,788 $108,000
Q3 2021 Oct 15, 2021	SELL	$67.69 - $73.03 $5,956 - $6,426	-88 Reduced 3.63%	2,337 $163,000
Q2 2021 Jul 15, 2021	SELL	$63.47 - $69.35 $207,229 - $226,427	-3,265 Reduced 57.38%	2,425 $167,000
Q1 2021 Apr 15, 2021	SELL	$60.0 - $68.46 $27,840 - $31,765	-464 Reduced 7.54%	5,690 $368,000
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $394,510 - $449,526	-6,964 Reduced 53.09%	6,154 $359,000
Q3 2020 Oct 08, 2020	BUY	$62.1 - $78.08 $5,464 - $6,871	88 Added 0.68%	13,118 $829,000
Q2 2020 Jul 13, 2020	SELL	$72.34 - $84.0 $10,851 - $12,600	-150 Reduced 1.14%	13,030 $1 Million
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $6,263 - $8,022	-100 Reduced 0.75%	13,180 $985,000
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $85,343 - $93,875	-1,385 Reduced 9.44%	13,280 $863,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $19,065 - $21,045	-305 Reduced 2.04%	14,665 $929,000
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $106,107 - $118,986	-1,715 Reduced 10.28%	14,970 $1.01 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $40,957 - $45,882	-655 Reduced 3.78%	16,685 $1.09 Million
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $233,987 - $305,335	-3,865 Reduced 18.23%	17,340 $1.08 Million
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $54,172 - $59,979	-760 Reduced 3.46%	21,205 $1.64 Million
Q2 2018 Aug 20, 2018	SELL	$64.88 - $75.68 $98,942 - $115,412	-1,525 Reduced 6.49%	21,965 $1.56 Million
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $32,778 - $39,960	-450 Reduced 1.88%	23,490 $1.77 Million
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $36,642 - $43,012	-515 Reduced 2.11%	23,940 $1.72 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $1.76 Million - $2.09 Million	24,455	24,455 $1.98 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

News

Stay updated on City Holding CO with notifications on news.

Account